Patent · US Active

Pharmaceutically active disubstituted triazine derivatives

US9226929B2 · kind B2 · utility

3Cited by

0References

8Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Gerd Ruhter · Hamburg, DE
Uwe Koch · Roma, IT
Peter Nussbaumer · Schwanenstadt, AT
Carsten Schulz-Fademrecht · Dortmund, DE
Jan Eickhoff · Herdecke, DE

Key dates

Filing date	Mar 1, 2012
Grant date	Jan 5, 2016
Priority date	—
Expiry date	Mar 1, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to disubstituted triazine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, immunological diseases, autoimmune diseases, cardiovascular diseases, cell proliferative diseases, inflammation, erectile dysfunction and stroke, and pharmaceutical compositions containing at least one of said disubstituted triazine derivatives and/or pharmaceutically acceptable salts thereof. Furthermore, the present invention relates to the use of said disubstituted triazine derivatives as inhibitors for a protein kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.